Home › Compare › LOBEF vs BTI

LOBEF vs BTI: Dividend Comparison 2026

LOBEF yields 3861.00% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LOBEF wins by $5102776617539.96M in total portfolio value
10 years
LOBEF
LOBEF
● Live price
3861.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5102776617540.00M
Annual income
$4,855,397,881,919,778,000.00
Full LOBEF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — LOBEF vs BTI

📍 LOBEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLOBEFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LOBEF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LOBEF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LOBEF
Annual income on $10K today (after 15% tax)
$328,185.33/yr
After 10yr DRIP, annual income (after tax)
$4,127,088,199,631,811,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, LOBEF beats the other by $4,127,088,199,631,808,500.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LOBEF + BTI for your $10,000?

LOBEF: 50%BTI: 50%
100% BTI50/50100% LOBEF
Portfolio after 10yr
$2551388308770.02M
Annual income
$2,427,698,940,959,890,400.00/yr
Blended yield
95.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

LOBEF
No analyst data
Altman Z
-9.3
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LOBEF buys
0
BTI buys
0
No recent congressional trades found for LOBEF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLOBEFBTI
Forward yield3861.00% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$5102776617540.00M ✓$37.8K
Annual income after 10y$4,855,397,881,919,778,000.00 ✓$2,802.29
Total dividends collected$5085877075297.57M ✓$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LOBEF vs BTI ($10,000, DRIP)

YearLOBEF PortfolioLOBEF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$396,800$386,100.39$11,301$601.08+$385.5K → LOBEF
2$14,742,780$14,318,203.95$12,799$706.58+$14.73M → LOBEF
3$512,952,973$497,178,198.17$14,527$832.38+$512.94M → LOBEF
4$16,715,748,598$16,166,888,916.48$16,527$982.75+$16715.73M → LOBEF
5$510,255,139,456$492,369,288,456.53$18,846$1,162.95+$510255.12M → LOBEF
6$14,592,492,784,652$14,046,519,785,434.00$21,545$1,379.49+$14592492.76M → LOBEF
7$391,042,310,644,499$375,428,343,364,921.60$24,694$1,640.41+$391042310.62M → LOBEF
8$9,820,789,713,309,148$9,402,374,440,919,534.00$28,378$1,955.69+$9820789713.28M → LOBEF
9$231,195,080,018,900,830$220,686,835,025,660,030.00$32,702$2,337.79+$231195080018.87M → LOBEF
10$5,102,776,617,540,002,000$4,855,397,881,919,778,000.00$37,794$2,802.29+$5102776617539.96M → LOBEF

LOBEF vs BTI: Complete Analysis 2026

LOBEF — Stock

Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

Full LOBEF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this LOBEF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LOBEF vs SCHDLOBEF vs JEPILOBEF vs OLOBEF vs KOLOBEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.